These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 7178221

  • 21. [Proceedings: Effect of a dopamine-beta-hydroxylase inhibitor (fusaric acid) on thyroid hormones and TSH].
    Yoshimura M, Yatani T, Ochi Y, Nagasaka A, Takeda A.
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb 20; 50(2):88. PubMed ID: 4476662
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Antihypertensive effect of trifluoropentoxypicolinic acid: a pharmacokinetic study].
    Horisaka K, Masuda S.
    Nihon Yakurigaku Zasshi; 1984 Apr 20; 83(4):301-7. PubMed ID: 6745810
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Effects of fusaric acid calcium on catecholamine metabolism and its clinical effects on essential hypertension].
    Ozawa M, Nakajima Y, Suzuki K, Sato T, Takahashi E.
    Horumon To Rinsho; 1976 Jan 20; 24(1):79-86. PubMed ID: 942902
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Synthesis of 5-(substituted alkyl) picolinic acids. The dopamine beta-hydroxylase inhibitors. II.
    Miyano K, Sakasai T, Hamano H.
    Chem Pharm Bull (Tokyo); 1978 Aug 20; 26(8):2328-33. PubMed ID: 709695
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Proceedings: In vivo inhibition of dopamine beta-hydroxylase and blood pressure.
    Hidaka H, Hara F, Harada N, Asano M.
    Jpn J Pharmacol; 1974 Aug 20; 24(0):s:25. PubMed ID: 4545737
    [No Abstract] [Full Text] [Related]

  • 34. [Effects of fusaric acid and its derivative on the cardiovascular system].
    Furuta Y, Washizaki M.
    Nihon Yakurigaku Zasshi; 1976 Mar 20; 72(2):139-44. PubMed ID: 987962
    [Abstract] [Full Text] [Related]

  • 35. [Fundamental studies on fusaric acid and calcium fusarate. Acute toxicity and antihypertensive effects (author's transl)].
    Matsuzaki M, Nakamura K, Akutsu S, Onodera K, Sekino M.
    Jpn J Antibiot; 1976 May 20; 29(5):439-55. PubMed ID: 933335
    [No Abstract] [Full Text] [Related]

  • 36. Effect of fusaric acid (a dopamine beta-hydroxylase inhibitor) on phaeochromocytoma.
    Nagasaka A, Hara I, Imai Y, Uchikawa T, Yamauchi K, Suzuki S, Takatsuki K, Tomita A, Niinomi M, Nakagawa H.
    Clin Endocrinol (Oxf); 1985 Apr 20; 22(4):437-44. PubMed ID: 3987067
    [Abstract] [Full Text] [Related]

  • 37. Cytotoxic activity of fusaric acid on human adenocarcinoma cells in tissue culture.
    Fernandez-Pol JA, Klos DJ, Hamilton PD.
    Anticancer Res; 1993 Apr 20; 13(1):57-64. PubMed ID: 8476229
    [Abstract] [Full Text] [Related]

  • 38. Fusaric acid derivatives and analogues as possible antihypertensive agents. Note III.
    Colautti A, Rubessa F, Vio L.
    Farmaco Sci; 1981 Apr 20; 36(4):274-82. PubMed ID: 7250361
    [No Abstract] [Full Text] [Related]

  • 39. Preventive effect of fusaric acid, a dopamine beta-hydroxylase inhibitor, on the gastric ulceration induced by water-immersion stress in rats.
    Osumi Y, Takaori S, Fujiwara M.
    Jpn J Pharmacol; 1973 Dec 20; 23(6):904-6. PubMed ID: 4544702
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.